These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11217543)

  • 1. [Weight gain and antipsychotic drug treatment].
    Patri E; Dantchev N; Martinez M
    Encephale; 2000; 26(6):93-7. PubMed ID: 11217543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain associated with neuroleptic medication: a review.
    Stanton JM
    Schizophr Bull; 1995; 21(3):463-72. PubMed ID: 7481576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Study of 60 Candidate Genes with Antipsychotic-induced Weight Gain in Schizophrenia Patients.
    Ryu S; Huh IS; Cho EY; Cho Y; Park T; Yoon SC; Joo YH; Hong KS
    Pharmacopsychiatry; 2016 Mar; 49(2):51-6. PubMed ID: 26845588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight change and atypical antipsychotic treatment in patients with schizophrenia.
    Jones B; Basson BR; Walker DJ; Crawford AM; Kinon BJ
    J Clin Psychiatry; 2001; 62 Suppl 2():41-4. PubMed ID: 11232752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic induced weight gain: pathophysiology and management.
    Ananth J; Venkatesh R; Burgoyne K; Gadasalli R; Binford R; Gunatilake S
    Ann Clin Psychiatry; 2004; 16(2):75-85. PubMed ID: 15328901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weight gain during treatment with antipsychotics: clinical relevance, pathophysiology, and therapeutical strategies].
    Himmerich H; Schuld A; Pollmächer T
    Psychiatr Prax; 2004 Nov; 31 Suppl 2():S233-7. PubMed ID: 15586316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experience of weight gain as a result of taking second-generation antipsychotic medications: the mental health consumer perspective.
    Usher K; Park T; Foster K
    J Psychiatr Ment Health Nurs; 2013 Nov; 20(9):801-6. PubMed ID: 23146024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eating-behavior changes associated with antipsychotic medications in patients with schizophrenia as measured by the drug-related eating behavior questionnaire.
    Ryu S; Nam HJ; Oh S; Park T; Lim M; Choi JS; Baek JH; Jang JH; Park HY; Kim SN; Joo YH; Kwon JS; Hong KS
    J Clin Psychopharmacol; 2013 Feb; 33(1):120-2. PubMed ID: 23277254
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight change with atypical antipsychotics in the treatment of schizophrenia.
    Haddad P
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Body weight increase: a side effect of zotepin (Nipolept)?].
    Wetterling T; Müssigbrodt H
    Nervenarzt; 1996 Mar; 67(3):256-61. PubMed ID: 8901286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study].
    Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
    Recenti Prog Med; 2009 Feb; 100(2):103. PubMed ID: 19350804
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and weight management: a systematic review of interventions to control weight.
    Faulkner G; Soundy AA; Lloyd K
    Acta Psychiatr Scand; 2003 Nov; 108(5):324-32. PubMed ID: 14531752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of antipsychotic treatments on the motivation to eat: preliminary results in 153 schizophrenic patients.
    Sentissi O; Viala A; Bourdel MC; Kaminski F; Bellisle F; Olié JP; Poirier MF
    Int Clin Psychopharmacol; 2009 Sep; 24(5):257-64. PubMed ID: 19606055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism.
    Reynolds GP; Zhang ZJ; Zhang XB
    Lancet; 2002 Jun; 359(9323):2086-7. PubMed ID: 12086765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.